Tuesday, September 13, 2011

Aspire Appoints New Medical Director

Aspire IRB Appoints New Medical Director

For More Information Contact:

Alycia Huston
Phone: 619-469-0108
Email: alycia@aspire-irb.com

FOR IMMEDIATE RELEASE
September 13, 2011


Aspire IRB Welcomes New Medical Director

SAN DIEGO, Calif. (Sept 13, 2011) - Aspire IRB recently announced the appointment of Jon Holmlund, MD to the company's medical director post. As medical director, Dr. Holmlund is responsible for providing medical and scientific expertise and leadership to ensure the protection of people participating in human research studies reviewed and overseen by Aspire.

"Dr. Holmlund's background is a complementary blend of clinical research and administrative experience," said Alycia Huston, CEO of Aspire. "We're thrilled to have him onboard, and know that we'll benefit from his accomplished background and clear passion for ethics and subject safety."

With over two decades of experience in medical oncology and cancer therapeutics studies, Dr. Holmlund has acquired a broad range of knowledge in the medical testing and research fields. Prior to joining the Aspire team, Dr. Holmlund served as an independent consultant to the biopharmaceutical industry. He has also held the titles of Chief Medical Officer for Ascenta Therapeutics; Vice President of Development for Isis Pharmaceuticals; and Senior Investigator and Project Director for several programs of the National Cancer Institute (NCI).

"Aspire IRB is exceptionally professional-but the staff is also warm and approachable," said Dr. Holmlund. "They have a remarkable handle on the balance between the regulatory and ethical aspects of human subject research, and I look forward to collaborating with them."

Dr. Holmlund received his MD from SUNY-Buffalo in 1984, and completed his postgraduate medical training in Internal Medicine and Oncology at George Washington University Medical Center in Washington, DC. Rather than establishing an office practice after his training, Dr. Holmlund joined the NCI to deliver patient care in the context of therapeutics research. Dedicated to the ongoing pursuit of academic excellence, he is currently working toward an MA in Bioethics at Trinity International University in Deerfield, IL-which he will finish in 2012.

************************************************************************************************************************************************

About Aspire IRB: With over three decades of combined IRB experience, Aspire IRB is certified by the Women's Business Enterprise National Council. The company is also a certified minority-owned business through the National Minority Development Supplier and is committed to growth, quality research and the ethical protection of human subjects. Aspire IRB desires to build lasting client partnerships through timely, efficient service and quality communication.